Antibody tailoring for success
FairJourney Biologics: the “mission impossible” antibody company!
An antibody is easy to make, THE antibody is a job for FairJourney
Credentials & Testimonials
“FairJourney Biologics was founded by a group of scientists that have a significant track record in generating therapeutic antibodies to industry standards. They have consistently impressed us with their speed and expertise.”Mark Throsby
News & Events
FairJourney Biologics’ CSO Maria Pajuelo will make a presentation about Triple Vector for Discovery of Antibody Molecules in Full Therapeutic Format, at the 9th annual of PEGS Europe – Protein & Antibody Engineering Summit, on Tuesday, 14th of November 2017, at 2:55pm, in Lisbon, Portugal.
FairJourney Biologics will be attending BioPharm America 2017, that will take place on 26-27 September 2017, in Boston, United States.
A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels
FairJourney Biologics co-authors a Nature Medicine paper entitled: A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels. Nat Med. 2017 Aug 21. doi: 10.1038/nm.4390.